ArticleOncotarget2017
Targeting of CCN2 suppresses tumor progression and improves chemo-sensitivity in urothelial bladder cancer.
Xiaojing Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it